今天看啥  ›  专栏  ›  Claudisiran药药

德康业绩后暴跌36%:会议纪要

Claudisiran药药  · 公众号  ·  · 2024-07-26 09:19

文章预览

近期跟踪公司 2seventy bi o, Abbvie, Alnylam , Amgen, ALX  oncology , Argenx , Astrazeneca , Avidity , Bluebird , BMS, Biogen, Crinetics , Eisai, Eli Lilly, Genentech, Gilead, HCA , Itra-cellular, IOVANCE, J , Larimar, Legend,Medtronic, Merck,   Moderna, Novartis , Pfizer, Pliant , Regeneron, Roche, SAGIMET , S anof i , Sarepta, Vertex 虽然我也不懂医疗器械,但这么大个公司盘后跌了这么多还是必须勾引了我的注意力,让我康康到底发生了什么,有没有GLP-1的锅? 更多会议纪要可以上 知识星球 下载: Transcript : DexCom, Inc., Q2 2024 Earnings Call, Jul 25, 2024 July 25, 2024 at 04:30 pm EDT Presentation Operator Message Operator  (Operator) Welcome to the DexCom Second Quarter 2024 Earnings Release Conference Call. My name is Abby, and I'll be your operator for today's call. [Operator Instructions] As a reminder, the conference is being recorded. I will now ………………………………

原文地址:访问原文地址
快照地址: 访问文章快照
总结与预览地址:访问总结与预览